Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion description "[We designed a neoadjuvant and adjuvant clinical trial comparing an irradiated, granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting, allogeneic PDAC vaccine (GVAX) given as a single agent or in combination with low-dose cyclophosphamide to deplete regulatory T cells (Treg) as a means to study how the TME is altered by immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion evidence source_evidence_literature NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion SIO_000772 24942756 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion wasDerivedFrom befree-2016 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion wasGeneratedBy ECO_0000203 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.